Latest News
-

HD just got cilia
⏱️ 5 min read
Huntington's disease just got cilia: huntingtin protein affects tiny but important hairs on cells called cilia
-

Gene silencing takes a targeted step forward
⏱️ 6 min read
Targeting the mutant Huntington's disease gene for silencing, while leaving the healthy gene untouched
-

Prana Biotech's new trial of PBT2 in Huntington's disease: the lowdown
⏱️ 7 min read
Prana Biotech's PBT2 trial in Huntington's disease: what we know so far & what copper has to do with the mutant prote
-

Oz Buzz Video: Day 2
⏱️ 25 min read
The final day of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-

Oz Buzz Video: Day 1
⏱️ 32 min read
Day 1 of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-

Oz Buzz Updates: Day 3
⏱️ 5 min read
Day 3 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-

Oz Buzz Updates: Day 2
⏱️ 6 min read
Day 2 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-

Oz Buzz Updates: Day 1
⏱️ 4 min read
Day 1 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
-

Stand By for Oz Buzz
⏱️ 3 min read
Follow @HDBuzzFeed and send your questions for the World Congress on Huntington's disease
-

Ten golden rules for reading a scientific news story
⏱️ 8 min read
Avoid the hype: HDBuzz presents ten 'golden rules' for reading a news story or press release about Huntington's disea
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
“A Whole World of Unknown”: How Couples Live Between Today and Tomorrow with HD
-
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
-
Skyhawk’s drug trial takes flight in the US
-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
